Novel derivatives of gamma-endorphins, intermediates therefor, and compositions and methods employing said derivatives
OwnerDavid H. Coy, Abba J. Kastininventors
Life of this patent
Estimating the term…
Loading patent…
OwnerDavid H. Coy, Abba J. Kastininventors
Estimating the term…
Novel .gamma.-endorphins represented by the formula 1 H-Tyr-X-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Y wherein: X is a chiral residue of a D-amino acid selected from the group consisting of D-alanine, D-leucine, D-isoleucine, D-valine, D-phenylalanine, D-tyrosine, D-tryptophan, D-serine, D-threonine, D-methionine, D-glutamic acid, D-glutamine, D-proline D-aspartic acid, D-asparagine, D-lysine, D-arginine and D-histidine; and Y is selected from the group consisting of hydroxy, amino, loweralkylamino, diloweralkylamino and lower alkoxy; and the pharmaceutically acceptable salts thereof; intermediates useful in making the novel compounds; and pharmaceutical compositions and methods employing the novel compounds.
A heptadecapeptide represented by the formula
A hexadecapeptide having the following amino acid sequence:
D-Ala.sup.2 -.beta.-lipotropin fragment 61-77 or a pharmaceutically acceptable salt thereof.
D-Ala.sup.2 -.beta.-lipotropin fragment 61-77 amide or a pharmaceutically acceptable salt thereof.
Novel heptadecapeptides of the formula
Dependencies are inferred from the claim text.